Part of our Psychedelics 2021: A Year in Review Series See the full series 2022 looks set to be another busy year for the psychedelics space, with a number of late-stage clinical trials commencing or wrapping; important decisions on the table for Oregon’s legal supervised psilocybin therapy rollout in 2023; further (psychedelic) drug policy reform efforts set to progress; and much, much more.


Previous articleMydecine Welcomes Dr. Victoria Hale as Newest Independent Board Member
Next articleReligious Practice Under Oregon Measure 109